MEDP:NGS-Medpace Holdings Inc. (USD)

EQUITY | Diagnostics & Research | Nasdaq Global Select

Last Closing

USD 377

Change

-8.16 (-2.12)%

Market Cap

USD 1.47B

Volume

0.32M

Analyst Target

USD 118.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-02 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IDXX IDEXX Laboratories Inc

N/A

USD 38.79B
ICLR ICON PLC

N/A

USD 25.88B
ILMN Illumina Inc

N/A

USD 20.48B
NTRA Natera Inc

N/A

USD 14.01B
EXAS EXACT Sciences Corporation

N/A

USD 11.40B
RDNT RadNet Inc

N/A

USD 4.64B
SHC Sotera Health Co

N/A

USD 4.37B
NEOG Neogen Corporation

N/A

USD 3.49B
GH Guardant Health Inc

N/A

USD 3.00B
MYGN Myriad Genetics Inc

N/A

USD 2.49B

ETFs Containing MEDP

AJEUAS:SW UBS (Irl) Fund Solutions .. 96.30 % 0.00 %

N/A

N/A
S6EW:SW Ossiam STOXX® Europe 600.. 4.65 % 0.00 %

N/A

USD 0.11B
XCLN:CA iShares Global Clean Ener.. 4.02 % 0.00 %

N/A

CAD 9.38M
ZCLN:CA BMO Clean Energy Index ET.. 4.02 % 0.00 %

N/A

CAD 0.07B
INRG:SW iShares Global Clean Ener.. 4.02 % 0.00 %

N/A

USD 2.91B
INRE:PA iShares Global Clean Ener.. 4.02 % 0.00 %

N/A

N/A
AMID Argent Mid Cap ETF 3.71 % 0.00 %

N/A

N/A
EUDI:LSE SPDR® S&P Euro Dividend .. 3.71 % 0.00 %

N/A

USD 0.99B
EUDV:LSE SPDR® S&P Euro Dividend .. 3.71 % 0.00 %

N/A

USD 0.99B
PTH Invesco DWA Healthcare Mo.. 3.60 % 0.60 %

N/A

USD 0.14B
EUDV:SW SPDR® S&P Euro Dividend .. 3.48 % 0.00 %

N/A

N/A
STUX:SW SPDR® MSCI Europe Utilit.. 2.89 % 0.00 %

N/A

USD 0.12B
ASRS:F BNP Paribas Easy ECPI Glo.. 2.67 % 0.00 %

N/A

N/A
HYDRO:PA BNP Paribas Easy ECPI Glo.. 2.67 % 0.00 %

N/A

N/A
HYDUS:PA BNP Paribas Easy ECPI Glo.. 2.67 % 0.00 %

N/A

N/A
JSMD Janus Henderson Small/Mid.. 2.20 % 0.50 %

N/A

USD 0.36B
REUSE:PA BNP Paribas Easy ECPI Cir.. 2.14 % 0.00 %

N/A

N/A
REUSD:PA BNP Paribas Easy ECPI Cir.. 2.14 % 0.00 %

N/A

N/A
QSML:AU VanEck MSCI International.. 1.45 % 0.00 %

N/A

N/A
ICLN iShares Global Clean Ener.. 0.00 % 0.46 %

N/A

USD 2.18B
RFG Invesco S&P MidCap 400® .. 0.00 % 0.35 %

N/A

N/A
INFR ClearBridge Sustainable I.. 0.00 % 0.47 %

N/A

USD 8.31M
SMLF iShares MSCI USA Small-Ca.. 0.00 % 0.30 %

N/A

N/A
INRG:LSE iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

N/A
L6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

USD 0.12B
LCPE:LSE Ossiam Shiller Barclays C.. 0.00 % 0.00 %

N/A

USD 0.17B
S6EW:LSE Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

N/A
JELS:LSE 0.00 % 0.00 %

N/A

N/A
UTIL:LSE SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

N/A

USD 0.12B
EUDV:PA SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.99B
S6EW:PA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

USD 0.12B
STU:PA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

N/A

USD 0.12B
IQQH:F iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

N/A
OSX6:F Ossiam Lux - Ossiam Stoxx.. 0.00 % 0.00 %

N/A

N/A
SPYU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
SPYW:F SPDR S&P Euro Dividend Ar.. 0.00 % 0.00 %

N/A

N/A
DXSH:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

N/A

USD 0.03B
IQQH:XETRA iShares Global Clean Ener.. 0.00 % 0.00 %

N/A

USD 3.34B
OSX6:XETRA Ossiam Stoxx Europe 600 E.. 0.00 % 0.00 %

N/A

USD 0.16B
SPYU:XETRA SPDR® MSCI Europe Utilit.. 0.00 % 0.00 %

N/A

USD 0.16B
SPYW:XETRA SPDR S&P Euro Dividend Ar.. 0.00 % 0.00 %

N/A

USD 0.97B
IBBJ 0.00 % 0.00 %

N/A

N/A
EMEC:XETRA BNP Paribas Easy ECPI Cir.. 0.00 % 0.00 %

N/A

USD 0.62B
VCLN Virtus Duff & Phelps Clea.. 0.00 % 0.00 %

N/A

USD 5.21M

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 22.99% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.99% 88% B+ 85% B
Trailing 12 Months  
Capital Gain 45.70% 90% A- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.70% 90% A- 90% A-
Trailing 5 Years  
Capital Gain 392.94% 100% F 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 392.94% 100% F 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 45.89% 82% B 90% A-
Dividend Return 45.89% 82% B 90% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.77% 66% D+ 44% F
Risk Adjusted Return 115.40% 100% F 99% N/A
Market Capitalization 1.47B 91% A- 94% A

Key Financial Ratios

  Ratio vs. Industry/Classification (Diagnostics & Research) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 128.40 43% 28%
Price/Book Ratio 21.90 7% 5%
Price / Cash Flow Ratio 27.56 14% 11%
Price/Free Cash Flow Ratio 33.42 7% 8%
Management Effectiveness  
Return on Equity 58.86% 98% 98%
Return on Invested Capital 57.06% 100% 96%
Return on Assets 14.33% 98% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.